Genomic profiling and a NGS analysis of 571 cancer associated genes revealed no differences in CN (Supplementary Fig. 3) and mutation profile between the parental and the palbo-resistant PDX: with both carrying a mutation in PIK3CA (His1047Arg) and a TP53 mutation (Arg248Trp). This evidence concerns the gene TP53 and cancer.